Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from Californiconus californicus, for Treating Type 2 Diabetes

The FDA’s approval of peptide drugs such as Ziconotide or Exendin for pain relief and diabetes treatment, respectively, enhanced the interest to explore novel conotoxins from Conus species venom. In general, conotoxins can be used in pathologies where voltage-gated channels, membrane receptors, or l...

Descripción completa

Detalles Bibliográficos
Autores principales: Lugo-Fabres, Pavel H., Otero-Sastre, Leslie M., Bernáldez-Sarabia, Johanna, Camacho-Villegas, Tanya A., Sánchez-Campos, Noemi, Serrano-Bello, Janeth, Medina, Luis A., Muñiz-Hernández, Saé, de la Cruz, Lizbeth, Arenas, Isabel, Barajas-Martínez, Antonio, Garcia, David E., Nuñez-Garcia, Linda, González-Canudas, Jorge, Licea-Navarro, Alexei F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391312/
https://www.ncbi.nlm.nih.gov/pubmed/34440140
http://dx.doi.org/10.3390/biomedicines9080936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391312/
https://www.ncbi.nlm.nih.gov/pubmed/34440140
http://dx.doi.org/10.3390/biomedicines9080936

Ejemplares similares